Case Report

CellMed 2022; 12(4): 18.1-18.2

Published online November 30, 2022

https://doi.org/10.5667/CellMed.2022.018

© Cellmed Orthocellular Medicine and Pharmaceutical Association

Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer

Han, Inhee

Haninhee Onnuri Pharmacy

Correspondence to : Haninhee Onnuri Pharmacy

Abstract

In Korea, liver cancer is the sixth most prevalent malignancy and the second leading cause of cancer-related mortality. The peak incidence of liver cancer deaths occurs between the ages of 40 and 59. (e.g. Yoon et al. 2021) The patient is a 69-year-old female with bronchiectasis as an underlying condition. She underwent left lower lobe resection for the disease, and in 2009 she was diagnosed with liver cancer and experienced a recurrence after a full recovery. In the case of such patients, the most effective OCNT prescription is recommended.

Keywords Ortho-Cellular Nutrition Therapy; OCNT; End-stage Liver Cancer; Liver Cancer

Article

Case Report

CellMed 2022; 12(4): 18.1-18.2

Published online November 30, 2022 https://doi.org/10.5667/CellMed.2022.018

Copyright © Cellmed Orthocellular Medicine and Pharmaceutical Association.

Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer

Han, Inhee

Haninhee Onnuri Pharmacy

Correspondence to:Haninhee Onnuri Pharmacy

Abstract

In Korea, liver cancer is the sixth most prevalent malignancy and the second leading cause of cancer-related mortality. The peak incidence of liver cancer deaths occurs between the ages of 40 and 59. (e.g. Yoon et al. 2021) The patient is a 69-year-old female with bronchiectasis as an underlying condition. She underwent left lower lobe resection for the disease, and in 2009 she was diagnosed with liver cancer and experienced a recurrence after a full recovery. In the case of such patients, the most effective OCNT prescription is recommended.

Keywords: Ortho-Cellular Nutrition Therapy, OCNT, End-stage Liver Cancer, Liver Cancer

CellMed
May 31, 2024 Vol.14 No.7, pp. 1.1~4.3

Stats or Metrics

Share this article on

  • line

CellMed